Brainsway Ltd (BWAY NASDAQ) stock market data APIs
$13.6263
-0.18(-1.3%)
as of September 14, 2026
Try our APIs with
free plan!
Brainsway Ltd Financial Data Overview
Price chart is built with
Anychart
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Prev. Close
13.6263
Open
13.4461
High
13.9407
Low
13.3454
52 wk Range
7.135-17.4
Market Cap
548 M
P/E Ratio
59.2609
Shares Outstanding
40 208 K
Revenue
60 695 K
EPS
0.14
Beta
0.079
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Brainsway Ltd (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Brainsway Ltd data using free add-ons & libraries
Get Brainsway Ltd Fundamental Data
Brainsway Ltd Fundamental data includes:
- Net Revenue: 60 695 K
- EBITDA: 8 483 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-12
- EPS/Forecast: 0.1
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Brainsway Ltd News
New
BrainsWay’s (BWAY) Growth Streak Just Got Harder To Ignore
On August 12, BrainsWay Ltd. (NASDAQ:BWAY) reported second-quarter 2026 results that make the neurostimulation company look less like a niche medtech story and more like a genuine growth compounder. R...
BrainsWay (BWAY) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Wed, Aug. 12, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Hadar Levy Chief Financial Officer - Ido Marom Need a quote from a Motley Fool a...
Brainsway Q2 Earnings Call Highlights
Key Points Interested in Brainsway Ltd. Sponsored ADR? Here are five stocks we like better. BrainsWay reported strong Q2 results, with revenue up 35% to $17.1 million, adjusted EBITDA up 141% to $3.5...
Here are the major earnings before the open Wednesday
Major earnings expected before the bell on Wednesday include: * Nebius Group N.V. (NBIS [https://seekingalpha.com/symbol/NBIS]) * Tencent Holdings Limited (TCEHY [https://seekingalpha.com/symbol/...
Get Brainsway Ltd fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
